Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
8.00
-0.09 (-1.11%)
At close: Feb 21, 2025, 4:00 PM
8.10
+0.10 (1.25%)
After-hours: Feb 21, 2025, 5:42 PM EST
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $883.69 million as of February 21, 2025. Its market cap has increased by 70.16% in one year.
Market Cap
883.69M
Enterprise Value
555.97M
1-Year Change
70.16%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $883.69M, an increase of 611.10%. That is a compound annual growth rate of 52.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 883.69M | 2.56% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |